Filter News
Area of Research
- (-) Biology and Soft Matter (1)
- (-) Computational Biology (2)
- Advanced Manufacturing (2)
- Biological Systems (1)
- Biology and Environment (77)
- Clean Energy (50)
- Climate and Environmental Systems (3)
- Computational Engineering (2)
- Computer Science (2)
- Fusion and Fission (4)
- Fusion Energy (1)
- Isotope Development and Production (1)
- Isotopes (10)
- Materials (71)
- Materials for Computing (9)
- Mathematics (1)
- National Security (29)
- Neutron Science (31)
- Nuclear Science and Technology (10)
- Quantum information Science (4)
- Supercomputing (87)
News Type
Media Contacts
![Elizabeth Herndon uses spectroscopic techniques at ORNL to analyze the chemical composition of leaves and other environmental samples to better understand the soil carbon cycle. Credit: Genevieve Martin/ORNL, U.S. Dept. of Energy](/sites/default/files/styles/list_page_thumbnail/public/2022-04/herndon1_0.jpg?h=e9eb73b3&itok=7hv7ziII)
ORNL biogeochemist Elizabeth Herndon is working with colleagues to investigate a piece of the puzzle that has received little attention thus far: the role of manganese in the carbon cycle.
![Genetic analysis revealed connections between inflammatory activity and development of atomic dermatitis, according to researchers from the UPenn School of Medicine, the Perelman School of Medicine, and Oak Ridge National Laboratory. Credit: Kang Ko/UPenn](/sites/default/files/styles/list_page_thumbnail/public/2022-02/Graves-AD_0.jpg?h=46d8a70d&itok=77AW7Swv)
University of Pennsylvania researchers called on computational systems biology expertise at Oak Ridge National Laboratory to analyze large datasets of single-cell RNA sequencing from skin samples afflicted with atopic dermatitis.
![An ORNL-led team comprising researchers from multiple DOE national laboratories is using artificial intelligence and computational screening techniques – in combination with experimental validation – to identify and design five promising drug therapy approaches to target the SARS-CoV-2 virus. Credit: Michelle Lehman/ORNL, U.S. Dept. of Energy](/sites/default/files/styles/list_page_thumbnail/public/2021-06/frame1.png?h=d1cb525d&itok=51pwBWyP)
An ORNL-led team comprising researchers from multiple DOE national laboratories is using artificial intelligence and computational screening techniques – in combination with experimental validation – to identify and design five promising drug therapy approaches to target the SARS-CoV-2 virus.